This chapter will review the pharmacotherapy for management of myasthenia crisis, Guillain-Barre syndrome, and antithrombotic-induced intracranial hemorrhage according to expert opinion. Myasthenia crisis Definitions Myasthenia gravis (MG) Autoimmune disease targeting…
This chapter will review the recommendations from the 2016 Surviving Sepsis Campaign by Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Definitions • Sepsis:…
This chapter will review the practice guidelines by the Infectious Diseases Society of America (IDSA). Note: Empiric antibiotics should be tailored based on local pathogen prevalence and antibiotic susceptibility, pathogen-specific…
This chapter will review the guidelines by the Infectious Diseases Society of America (IDSA). Note: Empiric antibiotics should be tailored based on local pathogen prevalence and antibiotic susceptibility, pathogen-specific risk…
This chapter will review the pharmacotherapy for management of severe acute pancreatitis and liver failure according to the American College of Gastroenterology and American Association for the Study of Liver…
This chapter will review the pharmacotherapy for management of gastrointestinal (GI) fistulas, postoperative ileus, nausea, and vomiting and upper GI bleeding according to expert opinion. GI fistulas Definition An abnormal…
This chapter will review the pharmacologic management of adrenal and thyroid dysfunction according to the clinical practice guidelines and expert opinion. Thyroid storm Definition A life-threatening condition caused by an…
This chapter will review the pharmacotherapy for treatment of high blood pressure according to the 2017 High Blood Pressure Clinical Practice Guideline. Definitions Hypertensive urgency Severe elevations in blood pressure…
This chapter will review the American Diabetes Association Practice Guidelines on diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). Introduction DKA and HHS are the two most serious acute complications…
